Institute Of Chemical Biology
-
New research offers promise for treatment-resistant cystic fibrosis patients
A recent study from the labs of Lars Plate and Jens Meiler, published in the Proceedings of the National Academy of Sciences of the United States of America, analyzed both selectively responsive and poorly responsive variants of cystic fibrosis and revealed the molecular determinants of drug response. Read MoreJun 12, 2025
-
Study uncovers significant differences in a dietary supplement’s key ingredient
A recent study by Paula Luis and Claus Schneider, researchers in the Vanderbilt University School of Medicine Basic Sciences Department of Pharmacology and the Vanderbilt Institute of Chemical Biology, has uncovered substantial inconsistencies in the alkaloid content of Corydalis yanhusuo dietary supplements. Read MoreMar 26, 2025
-
Vanderbilt-Ancora partnership advances research for rare form of epilepsy
Research in the Weaver lab leads to discoveries that help secure partnership with Ancora Innovation LLC. “Vanderbilt is at the forefront of genetic research. By understanding the genetic causes of disease opens exciting new opportunities to develop drugs to treat them more effectively,” said Matt Nelson, vice president, genetics and genomics, 3DC at Deerfield Management. Read MoreOct 27, 2022
-
Discovery of natural compound may help fend off antibiotic resistance of hard-to-treat infections
A bifunctional natural compound has been discovered with the potential to make antibiotic resistance to deadly infections less likely. Read MoreAug 19, 2020
-
Faster (cheaper) method for making big bioactive ring molecules
A pair of Vanderbilt chemists have developed a faster, cheaper method for synthesizing ring molecules called cyclic depsipeptides found in antibiotics, anti-retrovirals and pesticides. Read MoreDec 12, 2016